Apollo Endosurgery, Inc.
APEN
APEN was delisted on the 3rd of April, 2023.
71 hedge funds and large institutions have $173M invested in Apollo Endosurgery, Inc. in 2022 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 23 increasing their positions, 23 reducing their positions, and 14 closing their positions.
207% more call options, than puts
Call options by funds: $607K | Put options by funds: $198K
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
0% more repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 23
7% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 14
1% less funds holding
Funds holding: 72 → 71 (-1)
28% less capital invested
Capital invested by funds: $239M → $173M (-$66.1M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citigroup
New York
|
+$6.72M |
| 2 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$3.64M |
| 3 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$3.31M |
| 4 |
Invesco
Atlanta,
Georgia
|
+$1.9M |
| 5 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
+$1.61M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
-$3.51M |
| 2 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
-$2.32M |
| 3 |
HIM
Hillsdale Investment Management
Toronto,
Ontario, Canada
|
-$1.84M |
| 4 |
PGM
Parian Global Management
Pound Ridge,
New York
|
-$1.54M |
| 5 |
EI
EAM Investors
Solana Beach,
California
|
-$1.18M |
APEN Hedge Fund Activity: Q1 2022 in Review
71 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Apollo Endosurgery, Inc. (APEN) for Q1 2022, worth a combined $173M — down 28% from $239M a quarter earlier.
Sellers outnumbered buyers: 14 funds closed out of APEN and 13 opened new positions — a net loss of 1 holder — while 23 trimmed existing stakes and 23 added.
The largest buyer was Citigroup, adding an estimated $6.72M. The largest seller was Adage Capital Partners, exiting entirely with an estimated $3.51M sold.
- 71 institutional investors held Apollo Endosurgery, Inc. (APEN) as of Q1 2022, down from 72 in Q4 2021.
- Funds reported $173M of Apollo Endosurgery, Inc. stock for Q1 2022, down 28% quarter-over-quarter.
- 13 funds opened new Apollo Endosurgery, Inc. positions in Q1 2022 and 14 closed out, a net change of -1 holder.
- The largest Apollo Endosurgery, Inc. buyer in Q1 2022 was Citigroup, an estimated $6.72M added.
- The largest Apollo Endosurgery, Inc. seller in Q1 2022 was Adage Capital Partners, an estimated $3.51M sold.
Based on aggregated 13F filings for Q1 2022.